Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014 (2014), Article ID 897523, 12 pages
http://dx.doi.org/10.1155/2014/897523
Research Article

Overexpression of MMP13 Is Associated with Clinical Outcomes and Poor Prognosis in Oral Squamous Cell Carcinoma

1Oral Cancer Research and Coordinating Centre, Faculty of Dentistry, University of Malaya, 50603 Kuala Lumpur, Malaysia
2Department of Oro-Maxillofacial Surgical and Medical Sciences, Faculty of Dentistry, University of Malaya, 50603 Kuala Lumpur, Malaysia
3School of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan
4Centre of Preclinical Science Studies, Faculty of Dentistry, Universiti Teknologi MARA, 40450 Shah Alam, Selangor Darul Ehsan, Malaysia
5Department of Otorhinolaryngology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
6Department of Oral and Maxillofacial Surgery, Hospital Kuala Lumpur, 50300 Kuala Lumpur, Malaysia
7Department of Oral and Maxillofacial Surgery, Hospital Tengku Ampuan Rahimah, 41586 Klang, Malaysia
8Department of Oral Surgery, Hospital Umum Kuching, 93586 Kuching, Sarawak, Malaysia
9Oral Cancer Research Team, Cancer Research Initiatives Foundation, 47500 Selangor Darul Ehsan, Malaysia

Received 20 June 2014; Revised 22 August 2014; Accepted 8 September 2014; Published 23 October 2014

Academic Editor: Steffen Maune

Copyright © 2014 Vui King Vincent-Chong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. W. Neville and T. A. Day, “Oral cancer and precancerous lesions,” CA: A Cancer Journal for Clinicians, vol. 52, no. 4, pp. 195–215, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. C. R. Leemans, B. J. Braakhuis, and R. H. Brakenhoff, “The molecular biology of head and neck cancer,” Nature Reviews Cancer, vol. 11, no. 1, pp. 9–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Silvermam Jr., “Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge,” Journal of the American Dental Association, vol. 132, pp. 7S–11S, 2001. View at Google Scholar · View at Scopus
  5. D. Chin, G. M. Boyle, R. M. Williams et al., “Novel markers for poor prognosis in head and neck cancer,” International Journal of Cancer, vol. 113, no. 5, pp. 789–797, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. F. M. F. I. Daniel, R. R. Hoffmann, M. M. Campos, and L. S. Yurgel, “Main molecular markers of oral squamous cell carcinoma,” Applied Cancer Research, vol. 30, pp. 279–288, 2010. View at Google Scholar
  7. V. K. Vincent-Chong, A. Anwar, L. P. Karen-Ng et al., “Genome wide analysis of chromosomal alterations in oral squamous cell carcinomas revealed over expression of MGAM and ADAM9,” PLoS ONE, vol. 8, no. 2, Article ID e54705, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Vihinen and V.-M. Kähäri, “Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets,” International Journal of Cancer, vol. 99, no. 2, pp. 157–166, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. W. C. Scurry Jr. and B. C. Stack Jr., “Role of metalloproteins in the clinical management of head and neck squamous cell carcinoma,” Head & Neck, vol. 29, no. 12, pp. 1144–1155, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. M. Pendás, J. A. Uría, M. G. Jiménez, M. Balbín, J. P. Freije, and C. López-Otín, “An overview of collagenase-3 expression in malignant tumors and analysis of its potential value as a target in antitumor therapies,” Clinica Chimica Acta, vol. 291, no. 2, pp. 137–155, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Culhaci, K. Metin, E. Copcu, and E. Dikicioglu, “Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may reflect increased tumor invasiveness,” BMC Cancer, vol. 4, article 42, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Johansson, K. Airola, R. Grénman, A.-L. Kariniemi, U. Saaríalho-Kere, and V.-M. Kähäri, “Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck,” The American Journal of Pathology, vol. 151, no. 2, pp. 499–508, 1997. View at Google Scholar · View at Scopus
  13. M. Luukkaa, P. Vihinen, P. Kronqvist et al., “Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer,” Head and Neck, vol. 28, no. 3, pp. 225–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Johansson, M. Vaalamo, S. Grénman et al., “Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas,” The American Journal of Pathology, vol. 154, no. 2, pp. 469–480, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Krecicki, M. Fraczek, M. Jelen, M. Podhorska, T. Szkudlarek, and T. Zatonski, “Expression of collagenase-1 (MMP-1), collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngeal squamous cell carcinomas,” European Archives of Oto-Rhino-Laryngology, vol. 260, no. 9, pp. 494–497, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. D. Gu, J. Y. Li, M. Li, J. Gu, and X. T. Shi, “Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma,” The American Journal of Gastroenterology, vol. 100, pp. 1835–1843, 2005. View at Google Scholar
  17. J. M. del Casar Lizcano, F. V. Piñeiro, L. O. G. Sánchez et al., “Expression and clinical significance of collagenase-3 (MMP-13) in gastric cancer,” Gastroenterologia y Hepatologia, vol. 26, no. 1, pp. 1–7, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Airola, T. Karonen, M. Vaalamo et al., “Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas,” British Journal of Cancer, vol. 80, no. 5-6, pp. 733–743, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. P. J. Bostrom, L. Ravanti, N. Reunanen et al., “Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder,” International Journal of Cancer, vol. 88, no. 3, pp. 417–423, 2000. View at Google Scholar
  20. J. A. Uría, M. Balbín, J. M. López et al., “Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor,” American Journal of Pathology, vol. 153, no. 1, pp. 91–101, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Roeb, M. Arndt, B. Jansen, V. Schumpelick, and S. Matern, “Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas,” International Journal of Colorectal Disease, vol. 19, no. 6, pp. 518–524, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. P. Freije, I. Díez-Itza, M. Balbín et al., “Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas,” The Journal of Biological Chemistry, vol. 269, no. 24, pp. 16766–16773, 1994. View at Google Scholar · View at Scopus
  23. J.-R. Wang, X.-H. Li, X.-J. Gao et al., “Expression of MMP-13 is associated with invasion and metastasis of papillary thyroid carcinoma,” European Review for Medical and Pharmacological Sciences, vol. 17, no. 4, pp. 427–435, 2013. View at Google Scholar · View at Scopus
  24. M. Cazorla, L. Hernandez, A. Nadal et al., “Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx,” The Journal of Pathology, vol. 186, pp. 144–150, 1998. View at Publisher · View at Google Scholar
  25. A. A. Dünne, R. Mandic, S. Falkenberg, C. V. Dalchow, A. M. Sesterhenn, and J. A. Werner, “RT-PCR expression profiling of matrix metalloproteinases and their specific inhibitors in cell lines and fresh biopsies of squamous cell carcinomas of the head and neck,” In Vivo, vol. 19, no. 5, pp. 943–948, 2005. View at Google Scholar · View at Scopus
  26. P. O-Charoenrat, P. H. Rhys-Evans, and S. A. Eccles, “Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck,” Archives of Otolaryngology—Head and Neck Surgery, vol. 127, no. 7, pp. 813–820, 2001. View at Google Scholar · View at Scopus
  27. C. H. Chung, J. S. Parker, G. Karaca et al., “Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression,” Cancer Cell, vol. 5, no. 5, pp. 489–500, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. R. B. Zain, V. Athirajan, W. M. Ghani et al., “An oral cancer biobank initiative: a platform for multidisciplinary research in a developing country,” Cell & Tissue Banking, vol. 14, no. 1, pp. 45–52, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. L. H. Sobin, M. K. Gospodarowicz, and C. Wittekind, TNM Classification of Malignant Tumours, John Wiley & Sons, New York, NY, USA, 2011.
  30. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-CT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. B. D'haene, J. Vandesompele, and J. Hellemans, “Accurate and objective copy number profiling using real-time quantitative PCR,” Methods, vol. 50, no. 4, pp. 262–270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Kononen, L. Bubendorf, A. Kallioniemi et al., “Tissue microarrays for high-throughput molecular profiling of tumor specimens,” Nature Medicine, vol. 4, no. 7, pp. 844–847, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Bektas, E. Noetzel, J. Veeck et al., “The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer,” Breast Cancer Research, vol. 10, no. 4, article R58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. C.-L. Liao, M.-Y. Lee, Y.-S. Tyan et al., “Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study,” Journal of Translational Medicine, vol. 7, article 37, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Zlobec, R. Steele, L. Terracciano, J. R. Jass, and A. Lugli, “Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer,” Journal of Clinical Pathology, vol. 60, no. 10, pp. 1112–1116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. W.-C. Chiang, Y.-K. Wong, S.-C. Lin, K.-W. Chang, and C.-J. Liu, “Increase of MMP-13 expression in multi-stage oral carcinogenesis and epigallocatechin-3-gallate suppress MMP-13 expression,” Oral Diseases, vol. 12, no. 1, pp. 27–33, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Etoh, H. Inoue, Y. Yoshikawa, G. F. Barnard, S. Kitano, and M. Mori, “Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness,” Gut, vol. 47, no. 1, pp. 50–56, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. L. K. Mäkinen, V. Häyry, T. Atula et al., “Prognostic significance of matrix metalloproteinase-2, -8, -9, and -13 in oral tongue cancer,” Journal of Oral Pathology & Medicine, vol. 41, no. 5, pp. 394–399, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. D. G. Albertson, “Gene amplification in cancer,” Trends in Genetics, vol. 22, no. 8, pp. 447–455, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. S. M. Hewitt, J. Dear, and R. A. Star, “Discovery of protein biomarkers for renal diseases,” Journal of the American Society of Nephrology, vol. 15, no. 7, pp. 1677–1689, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Yamamoto, M. Yamamoto-Ibusuki, Y. Yamamoto, S. Fujiwara, and H. Iwase, “A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer,” BMC Cancer, vol. 13, article 217, 2013. View at Publisher · View at Google Scholar · View at Scopus